Timothy Ganey serves as Chief Scientific Officer for Vivex Biomedical, and formerly was Research Director, Orthopaedic Surgery at Atlanta Medical Center. From 2000-2003, he was President of the US division of co.don Tissue Engineering, a cell-based therapeutic company from Berlin, Germany. In that capacity, the first worldwide pre-clinical and clinical studies for intervertebral disc repair using autologous disc chondrocytes were completed. To date, this is the only trial that has 10-year follow-up data with positive results. Dr. Ganey has published extensively in a broad range of fields including anatomy, biochemistry, electron microscopy, comparative morphology, cell biology, and electro-physics, and regularly reviews manuscripts for several international journals. His laboratory work has been supported by national, local, and society grants, with achievements that include outstanding papers and top research awards from numerous societies.
Dr. Ganey has been instrumental in several technology development initiatives, among them the use of cell-based therapeutics, electric field transduction, and manufactured tissue-specific matrices for regenerative medicine. Patents include work stemming from pulsed-field delivery and artificial matrices for bone regeneration. Timothy Ganey received a BS/BA degree from the University of Illinois with a major in Chemistry and Biology, did post-graduate work in Electron Microscopy, and completed a Ph.D. at the University of South Florida. He understands the challenges of a shifting paradigm in medicine to regenerative treatment and supports engineering and scientifically-grounded marketing initiatives to support the transition.